Similar articles

• Initiation and continuation of pharmacological therapies in patients hospitalized for heart failure in Japan.

  Okami S, Lecomte C, Raad H, Aguila M, Mohrova Z, Takeichi M, Tsuchiya T, Ohlmeier C, Evers T, Michel A. Okami S, et al. Sci Rep. 2024 Apr 20;14(1):9095. doi: 10.1038/s41598-024-60011-y. Sci Rep. 2024. PMID: 38643208 Free PMC article.
• Patterns and predictors of evidence-based medication continuation among hospitalized heart failure patients (from Get With the Guidelines-Heart Failure).

  Krantz MJ, Ambardekar AV, Kaltenbach L, Hernandez AF, Heidenreich PA, Fonarow GC; Get With the Guidelines Steering Committee and Hospitals. Krantz MJ, et al. Am J Cardiol. 2011 Jun 15;107(12):1818-23. doi: 10.1016/j.amjcard.2011.02.322. Epub 2011 Apr 12. Am J Cardiol. 2011. PMID: 21482418
• Comparative effectiveness of continuation and maintenance treatments for persistent depressive disorder in adults.

  Machmutow K, Meister R, Jansen A, Kriston L, Watzke B, Härter MC, Liebherz S. Machmutow K, et al. Cochrane Database Syst Rev. 2019 May 20;5(5):CD012855. doi: 10.1002/14651858.CD012855.pub2. Cochrane Database Syst Rev. 2019. PMID: 31106850 Free PMC article.
• Initiation, Continuation, or Withdrawal of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction.

  Gilstrap LG, Fonarow GC, Desai AS, Liang L, Matsouaka R, DeVore AD, Smith EE, Heidenreich P, Hernandez AF, Yancy CW, Bhatt DL. Gilstrap LG, et al. J Am Heart Assoc. 2017 Feb 11;6(2):e004675. doi: 10.1161/JAHA.116.004675. J Am Heart Assoc. 2017. PMID: 28189999 Free PMC article.
• Continuation of Chronic Heart Failure Therapies During Heart Failure Hospitalization - a Review.

  Singhania G, Ejaz AA, McCullough PA, Kluger AY, Balamuthusamy S, Dass B, Singhania N, Agarwal A. Singhania G, et al. Rev Cardiovasc Med. 2019 Sep 30;20(3):111-120. doi: 10.31083/j.rcm.2019.03.562. Rev Cardiovasc Med. 2019. PMID: 31601085 Review.